Partnership to Improve Patient Care

  • Home
  • About
    • Mission and Priorities
    • Meet the Chairman
    • Steering Committee
    • PIPC Member List
    • Contact
  • The Issues
    • Action Center
    • Value Our Health
    • International
    • Where We Stand
    • Value Assessment Frameworks
    • Engaging Patients in Value-Based Payment
    • Patient-Centeredness in Research
  • Resources
    • Advocacy
    • Letters and Comments
    • PCORI Meeting Transcripts
    • Polling
    • Roundtables
    • White Papers
  • News
    • Press Releases
    • PIPC in the News
    • PIPC Weekly Update
    • PIPC Patients' Blog
    • Chairman's Corner
    • The Data Mine
  • Events
    • Nevada AB 259
    • QALY Panel
    • QALY Briefing
    • Past Webinars >
      • MFN/IPI Webinar 2025
      • Discrimination & Health Care
      • C & GT Webinar
      • ICER COVID Webinar
      • Value Our Health Briefing
      • ICER SCD Webinar
      • VOH Sickle Cell Webinar
      • Rare Disease Webinar
      • QALY Webinar
      • PCORI Advocacy Webinar
      • APM Webinar
      • Patient Empowerment Webinar
      • Value Assessments Briefing
    • Past PIPC Forums >
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
  • Home
  • About
    • Mission and Priorities
    • Meet the Chairman
    • Steering Committee
    • PIPC Member List
    • Contact
  • The Issues
    • Action Center
    • Value Our Health
    • International
    • Where We Stand
    • Value Assessment Frameworks
    • Engaging Patients in Value-Based Payment
    • Patient-Centeredness in Research
  • Resources
    • Advocacy
    • Letters and Comments
    • PCORI Meeting Transcripts
    • Polling
    • Roundtables
    • White Papers
  • News
    • Press Releases
    • PIPC in the News
    • PIPC Weekly Update
    • PIPC Patients' Blog
    • Chairman's Corner
    • The Data Mine
  • Events
    • Nevada AB 259
    • QALY Panel
    • QALY Briefing
    • Past Webinars >
      • MFN/IPI Webinar 2025
      • Discrimination & Health Care
      • C & GT Webinar
      • ICER COVID Webinar
      • Value Our Health Briefing
      • ICER SCD Webinar
      • VOH Sickle Cell Webinar
      • Rare Disease Webinar
      • QALY Webinar
      • PCORI Advocacy Webinar
      • APM Webinar
      • Patient Empowerment Webinar
      • Value Assessments Briefing
    • Past PIPC Forums >
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010

The PIPC Blog

PIPC Patient Blog: Andrew Sperling on ICER Process for Tardine Dyskenesia Treatment Review

6/12/2017

 
Picture
​NAMI is proud to be part of the movement to assess value of health care treatments and interventions, and to build an infrastructure for patient engagement throughout the healthcare system, particularly in the shift to value-based payment and delivery models. However, we think it’s crucial that any efforts to measure and assess value, incorporate the patient perspective, and consistently and meaningfully engage patients along the way.

​When organizations conducting value assessments initiate their work without engaging patients in the development of their fundamental research questions, we worry about its ultimate impact on affected patients.  Without the perspective of patients at the table, the real-life benefits and risks of treatment that matter to patients cannot be identified and measured.  Ultimately, if value is not measured from the patient’s perspective, patient access to important or necessary treatments could be impeded.  We are concerned this may be the result of the upcoming assessment of treatments for tardive dyskinesia (TD) by the Institute for Clinical and Economic Review.
 
We have several outstanding concerns with the materials ICER has released thus far.
 
Lack of patient engagement. While we are hopeful that the background and scope proposal recently published by the Institute for Clinical and Economic Review (ICER) for its planned effectiveness and value review of available treatments for tardive dyskinesia (TD) will be the exception, it is not off to a great start in terms of patient engagement.  It was not well-known that ICER was initiating this work, even for NAMI as the largest grassroots mental health organization. Therefore, organizations like ours that represent patients with this condition were forced to respond quickly.  While PIPC and others have long advocated for ICER to engage patients early and often in their work to assess the value of treatments, we are discouraged by the initial process for patient engagement and the lack of transparency that ICER was initiating this work. 
 
Failure to capture patient-centric outcomes. Though there is not a cure for TD, there are several promising treatments on the horizon. The possibility of an effective therapy to treat the disorder and manage symptoms would be of enormous value to patients, mitigating social isolation and the inability to interact with the public in settings. Any review of these new interventions must provide significant weight to the value of improving the quality of life for someone living with TD.
 
The study described by ICER fails to adequately take into account the personal burden that persons living with TD must bear every day. By limiting the focus to clinical effectiveness and economic impact, ICER review fails to consider the social impacts of TD, its impact on family caregivers and how TD contributes to other medical co-morbidities. We know limiting the scope of the review to schizophrenia is problematic and fails to capture the full breadth of the population impacted by TD, thereby limiting the utility of the review.
 
Failure to capture issues presented in real-world treatment scenarios. NAMI has experience to share about the challenges facing people living with TD seeking the right medication. Our NAMI 800 number Helpline takes hundreds of thousands of calls each year to assist people with mental illness in finding treatment. This has led us to take strong position against public policies that promote switching of medications. Yet, the proposed ICER scope document fails to consider the risk associated with such an approach and the lack of evidence supporting its effectiveness. In real-life clinical practice, reducing, replacing, or removing antipsychotic treatment can jeopardize recovery and stability for people living with a serious mental illness.
 
Inclusion of non-FDA approved indications. NAMI is very concerned that ICER’s proposed assessment specifically includes an off-label intervention for TD for which there is limited evidence in existing clinical treatment guidelines.  Many in NAMI’s consumer and family membership continue to struggle everyday with TD. For too many of them, outdated off-label treatment has not offered them relief from this disabling and enormously stigmatizing condition. The promise of two near therapies that offer some hope of improvement and recovery is long overdue.
 
While we may worry that the design of ICER’s proposed review for TD treatments will result in limited access to potentially promising therapies, we also know that organizations like PIPC, National Health Council, FasterCures, National Patient Advocate Foundation and others are working diligently on patient-centered value frameworks that are aligned with what matters to patients. Moving forward, we hope that ICER will follow PIPC’s lead to make value to the patient the top priority. 

Comments are closed.

    Topics

    All
    Alternative Payment Models
    Chairman's Corner
    Patient Centered Research
    PIPC In The News
    PIPC Patient Blog
    PIPC Weekly Update
    Press Releases
    The Data Mine
    Value Frameworks

    Archives

    June 2025
    May 2025
    April 2025
    March 2025
    February 2025
    January 2025
    December 2024
    November 2024
    October 2024
    September 2024
    August 2024
    July 2024
    June 2024
    May 2024
    April 2024
    March 2024
    February 2024
    January 2024
    December 2023
    November 2023
    October 2023
    September 2023
    August 2023
    July 2023
    June 2023
    May 2023
    April 2023
    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    April 2013
    March 2013
    December 2012
    November 2012
    February 2012
    September 2011
    August 2011
    July 2011
    May 2011
    March 2011
    November 2010
    October 2010
    September 2010
    August 2010
    April 2010
    March 2010
    February 2010
    December 2009
    September 2009
    July 2009
    June 2009
    May 2009
    February 2009
    January 2009
    December 2008

Powered by Create your own unique website with customizable templates.